Wells Fargo upgraded RxSight to Overweight from Equal Weight with a price target of $42, up from $31.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on RXST:
